Well I suspect a lot of people were interested in Valeant and the vast majority regret that interest.  Canada does not have a lot of quality blue chip healthcare companies.   There is a very real currency risk now by swinging into the US dollar.   If  Scott could provide a few suggestion worth exploring it would be very helpful.